Laurent Humeau Inovio Pharmaceuticals, Inc. (INO) insider trading activity

Laurent Humeau is Chief Scientific Officer of INOVIO PHARMACEUTICALS, INC.. Currently has a direct ownership of 24,337 shares of INO, which is worth approximately $217,329. The most recent transaction as insider was on May 15, 2024, when has been sold 1,703 shares (Common Stock) at a price of $13.07 per share, resulting in proceeds of $22,258. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.3K

14.42% 3M change

88.66% 12M change

Total Value Held $217,329

Laurent Humeau Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 15 2024	SELL Payment of exercise price or tax liability	$22,258 $13.07 p/Share	1,703 Reduced 6.54%	24,337 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	4,771 Added 15.48%	26,040 Common Stock
Feb 26 2024	SELL Payment of exercise price or tax liability	$19,184 $8.16 p/Share	2,351 Reduced 9.95%	21,269 Common Stock
Feb 26 2024	BUY Exercise of conversion of derivative security	-	5,734 Added 20.06%	22,850 Common Stock
Mar 11 2023	SELL Payment of exercise price or tax liability	$23,343 $1.13 p/Share	20,658 Reduced 8.78%	214,637 Common Stock
Mar 11 2023	BUY Exercise of conversion of derivative security	-	59,737 Added 20.25%	235,295 Common Stock
Feb 26 2023	SELL Payment of exercise price or tax liability	$35,759 $1.28 p/Share	27,937 Reduced 13.73%	175,558 Common Stock

Feb 26 2023	BUY Exercise of conversion of derivative security	-	68,811 Added 26.14%	194,426 Common Stock
Mar 11 2022	SELL Payment of exercise price or tax liability	$66,519 $3.22 p/Share	20,658 Reduced 13.3%	134,684 Common Stock
Mar 11 2022	SELL Payment of exercise price or tax liability	$66,519 $3.22 p/Share	20,658 Reduced 13.3%	134,684 Common Stock
Mar 11 2022	BUY Exercise of conversion of derivative security	-	59,737 Added 27.77%	155,342 Common Stock
Mar 11 2022	BUY Exercise of conversion of derivative security	-	59,737 Added 27.77%	155,342 Common Stock
Mar 08 2022	SELL Payment of exercise price or tax liability	$22,435 $3.26 p/Share	6,882 Reduced 6.71%	95,605 Common Stock
Mar 08 2022	BUY Exercise of conversion of derivative security	-	19,900 Added 16.26%	102,487 Common Stock
Feb 26 2022	SELL Payment of exercise price or tax liability	$27,515 $3.22 p/Share	8,545 Reduced 9.38%	82,587 Common Stock
Feb 26 2022	BUY Exercise of conversion of derivative security	-	22,545 Added 19.83%	91,132 Common Stock
Aug 09 2021	SELL Open market or private sale	$94,401 $9.15 p/Share	10,317 Reduced 13.08%	68,587 Common Stock
Jun 09 2021	SELL Open market or private sale	$93,584 $9.07 p/Share	10,318 Reduced 11.56%	78,904 Common Stock
Mar 11 2021	SELL Payment of exercise price or tax liability	$274,471 $10.57 p/Share	25,967 Reduced 22.54%	89,222 Common Stock
Mar 11 2021	BUY Exercise of conversion of derivative security	-	59,737 Added 34.15%	115,189 Common Stock
Mar 08 2021	SELL Payment of exercise price or tax liability	$61,319 $8.91 p/Share	6,882 Reduced 11.04%	55,452 Common Stock
Mar 08 2021	BUY Exercise of conversion of derivative security	-	19,900 Added 24.2%	62,334 Common Stock
Mar 05 2021	SELL Payment of exercise price or tax liability	$88,518 $9.19 p/Share	9,632 Reduced 18.5%	42,434 Common Stock
Mar 05 2021	BUY Exercise of conversion of derivative security	-	27,566 Added 34.62%	52,066 Common Stock
Nov 10 2020	SELL Open market or private sale	$189,794 $9.75 p/Share	19,466 Reduced 44.28%	24,500 Common Stock

Laurent Humeau

Chief Scientific Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INO shares.

Notify only if

Value

Insider Trading

Get notified when an Inovio Pharmaceuticals, Inc. insider buys or sells INO shares.

Notify only if

Operation

Value

Type

News

Receive news related to INOVIO PHARMACEUTICALS, INC.

Track Activities on INO

Account